Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $53.10 USD
Change Today -1.35 / -2.48%
Volume 3.0M
VTR On Other Exchanges
New York
As of 8:04 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Debra A. Cafaro J.D.

Chairman, Chief Executive Officer, Member of Executive Committee and Member of Investment Committee,Ventas, Inc.
AgeTotal Calculated CompensationThis person is connected to 127 board members in 7 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Ms. Debra A. Cafaro, J.D., has been the Chairman of Ventas, Inc., since January 28, 2003 and has been its Chief Executive Officer since March 5, 1999. Ms. Cafaro sathe Chief Executive Officer and President at Ventas Capital. She was the President from April 1997 to May 1998 and Director since April 1997 at Ambassador Apartments Inc. Ms. Cafaro was a Founding Member at Barack Ferrazzano in Chicago, where she practiced real estate, corporate, and finance law for 13 years. ...

Read Full Background

Corporate Headquarters*

353 North Clark Street
Chicago, Illinois 60654

United States

Phone: 877-483-6827
Fax: --

Board Members Memberships*

Chairman of the Board of Ventas Inc. - Corporate General Partner, Chief Executive Officer of Ventas - General Partner, President of Ventas - General Partner, Chief Executive Officer of Ventas Capital, President of Ventas Capital and Director of Ventas Capital
Chairman and Member of the Board of Governors
Chairman, Chief Executive Officer, Member of Executive Committee and Member of Investment Committee
Director, Chairman of Finance Committee and Member of Compensation Committee


BA 1979
University of Notre Dame
JD 1982
University of Chicago Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,050,000

Stock Options*

Restricted Stock Awards$3,622,850
All Other Compensation$60,518
Exercised Options447,613
Exercised Options Value$13,199,294
Exercisable Options849,260
Exercisable Options Value$15,456,258
Unexercisable Options295,227
Unexercisable Options Value$2,728,146
Total Value of Options$31,383,697
Total Number of Options1,910,041

Total Compensation*

Total Annual Cash Compensation$4,890,518
Total Short Term Compensation$1,050,000
Other Long Term Compensation$3,683,368
Total Calculated Compensation$10,066,018
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VTR:US $53.10 USD -1.35


Thomas J. DeRosa Chief Executive Officer, Director, Member of Executive Committee, Member of Planning Committee and Member of Investment Committee
Health Care REIT, Inc.
Lauralee E. Martin Chief Executive Officer, President, Director and Member of Stock Award Subcommittee
HCP, Inc.
C. Taylor Pickett CPAChief Executive Officer, President, Director and Member of Investment Committee
Omega Healthcare Investors Inc.
T. Andrew Smith Chief Executive Officer and Director
Brookdale Senior Living Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VENTAS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at